KRAS and neoplasm: These results suggest that CRC growth depends on tumor nutrient availability, KRAS mutation status, and E2; E2 exposure decreases CRC cell growth but has no significant effect when the cells harbor KRAS mutations and are cultured under nutrient-depleted conditions.